免疫系统
免疫抑制
癌症研究
放射治疗
生物
癌症
肿瘤微环境
免疫学
电离辐射
免疫疗法
癌细胞
医学
内科学
辐照
遗传学
物理
核物理学
作者
Michael Rückert,Ann-Sophie Flohr,Markus Hecht,Udo S. Gaipl
出处
期刊:Stem Cells
[Oxford University Press]
日期:2021-05-18
卷期号:39 (9): 1155-1165
被引量:84
摘要
Abstract Radiotherapy (RT) is still one of the standard cancer therapies, with up to two third of all cancer patients with solid tumors being irradiated in the course of their disease. The aim of using ionizing radiation in fractionated treatment schedules was always to achieve local tumor control by inducing DNA damage which can be repaired by surrounding normal tissue but leads to cell death in tumor cells. Meanwhile, it is known that RT also has immunological effects reshaping the tumor microenvironment. Nevertheless, RT alone often fails to elicit potent antitumor immune responses as these effects can be immunostimulatory as well as immunosuppressive. Here, we discuss how immunotherapies can be exploited in combined therapies to boost RT-induced antitumor immune responses or to counteract preexisting and RT-mediated immunosuppression to improve local and systemic tumor control. Furthermore, we highlight some parameters of radioimmunotherapies (RITs) which are under investigation for potential optimizations and how RIT approaches are tested in first phases II and III trials. Finally, we discuss how RT might affect normal and cancer stem cells.
科研通智能强力驱动
Strongly Powered by AbleSci AI